Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 362 Precursor Cell Lymphoblastic Leukemia-Lymphoma 89 Leukemia 61 Neoplasms, Plasma Cell 60 Lymphoma 59 Recurrence 52 Neoplasms 34 Vomiting 33 Lymphoma, Non-Hodgkin 32 Immunoglobulin Light-chain Amyloidosis 27 Lymphoma, Mantle-Cell 26 Burkitt Lymphoma 25 Nausea 22 Lymphoma, Large B-Cell, Diffuse 21 Leukemia, Lymphocytic, Chronic, B-Cell 21 Waldenstrom Macroglobulinemia 19 Prostatic Neoplasms 19 Lymphoma, Follicular 18 Hodgkin Disease 18 Neoplasm Metastasis 14 Breast Neoplasms 14 Amyloidosis 12 Lymphoma, B-Cell, Marginal Zone 11 Leukemia, Myeloid, Acute 11 Carcinoma, Non-Small-Cell Lung 11 Ovarian Neoplasms 9 Lymphoma, Large-Cell, Immunoblastic 9 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 8 Lymphoma, T-Cell, Cutaneous 8 Colonic Neoplasms 8

Interventions

midostaurin 2 vandetanib 1 selinexor 1 pegfilgrastim 1 Topotecan 1 Rituximab 1 Prednisone 1 Paclitaxel 1 Methylprednisolone 1 Immunologic Techniques 1 Ifosfamide 1 Flow Cytometry 1 Etoposide 1 Dexamethasone 1 Clofarabine 1 Carboplatin 1 Bexarotene 1 Alemtuzumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Aggression × Dexamethasone × Clear all

NCT02471911 2022-04-12

KPT-330+RICE

Weill Medical College of Cornell University

Phase 1 Completed

Aggression, Lymphoma, Large B-Cell, Diffuse

Data powered by HemOnc (CC BY 4.0) Colophon ⚡